JPMorgan shops $226m delta placement block for Telix’s con notes deal
Jul 23, 2024 – 5.20pmFund managers were being offered $US150 million ($226 million) worth of shares in cancer treatment hopeful Telix Pharmaceuticals after Tuesday’s close, as JPMorgan got going on the delta placement leg of a $600 million convertible notes deal in lieu of an abandoned Nasdaq listing.
Telix co-founder and CEO Christian Behrenbruch. Simon Schluter
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@copyright link
JPMorgan shops $226m delta placement block for Telix’s con notes...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.66 |
Change
0.475(2.48%) |
Mkt cap ! $6.433B | |||
| Open | High | Low | Value | Volume |
| $18.93 | $19.68 | $18.75 | $31.46M | 1.646M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 196 | $19.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.66 | 38 | 1 |
View Market Depth
| Last trade - 14.54pm 26/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |